ASH'22 will feature innovative methods for treating Diffuse Large B-cell Lymphoma (DLBCL) As the healthcare industry continues to comb through ASH abstracts for crucial insights before the 2022 annual conference, we at ZoomRx have used Ferma.AI, ZoomRx's comprehensive medical congress intelligence platform, to assemble
Conferences ASH'22: Showcasing cutting-edge approaches for treating Acute Myeloid Leukemia Abstracts for the American Society of Hematology’s (ASH) 64th Annual Meeting were released on November 3rd, in anticipation of opening remarks beginning in New Orleans on December 10. As the healthcare world
